Scholarlink

Purpose <p>No consensus has been reached regarding whether upfront versus deferred radiation to small, asymptomatic brain metastases is most optimal. We sought to assess the relationship between tumor size at radiation and subsequent development of local recurrence and radiation necrosis to make data-driven recommendations regarding timing of radiation utilization.</p> Methods <p>We identified 2268 patients with 6308 newly diagnosed brain metastases between 2010 and 2022 managed with brain-directed radiotherapy at Brigham and Women’s Hospital/Dana-Farber Cancer Institute (Boston, MA). Tumors were grouped by maximal unidimensional size: &lt;0.5&#xa0;cm, 0.5 to &lt; 1&#xa0;cm, 1&#xa0;cm to &lt; 2&#xa0;cm, and ≥ 2&#xa0;cm; local recurrence and radiation necrosis by tumor size were assessed using competing risks regression.</p> Results <p>Among metastases initially treated with stereotactic radiation or whole brain radiotherapy, lesions 1 to &lt; 2&#xa0;cm (HR 2.30 [95% CI, 1.38–3.81], <i>p</i> = 0.001 and HR 2.61 [95% CI 1.76–3.89], <i>p</i> &lt; 0.001, respectively) and ≥ 2&#xa0;cm (HR 3.10 [95% CI, 1.62–5.94], <i>p</i> &lt; 0.001 and HR 3.03 [95% CI 1.92–4.79], <i>p</i> &lt; 0.001, respectively) displayed greater local recurrence compared to tumors &lt; 0.5&#xa0;cm. In addition, among patients treated with stereotactic radiation, significantly higher risk of radiographic and symptomatic necrosis was observed in tumors ≥ 0.5&#xa0;cm versus &lt; 0.5&#xa0;cm at radiotherapy, with hazard ratios ranging from 3.27 to 18.90.</p> Conclusion <p>Larger metastasis size is associated with markedly poorer local control and increased necrosis following brain-directed radiation, suggesting a role for earlier utilization of radiation therapy in patients with small, asymptomatic metastases and a favorable prognosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis

  • 期刊论文

  • 发表日期：

    2025年4月15日

查看全文
  • Narmeen S. Rashid,
  • Nayan Lamba,
  • Paul J. Catalano,
  • Hesham Elhalawani,
  • Shyam K. Tanguturi,
  • Rifaquat Rahman,
  • Daphne A. Haas-Kogan,
  • Patrick Y. Wen,
  • Ayal A. Aizer

摘要

Purpose

No consensus has been reached regarding whether upfront versus deferred radiation to small, asymptomatic brain metastases is most optimal. We sought to assess the relationship between tumor size at radiation and subsequent development of local recurrence and radiation necrosis to make data-driven recommendations regarding timing of radiation utilization.

Methods

We identified 2268 patients with 6308 newly diagnosed brain metastases between 2010 and 2022 managed with brain-directed radiotherapy at Brigham and Women’s Hospital/Dana-Farber Cancer Institute (Boston, MA). Tumors were grouped by maximal unidimensional size: <0.5 cm, 0.5 to < 1 cm, 1 cm to < 2 cm, and ≥ 2 cm; local recurrence and radiation necrosis by tumor size were assessed using competing risks regression.

Results

Among metastases initially treated with stereotactic radiation or whole brain radiotherapy, lesions 1 to < 2 cm (HR 2.30 [95% CI, 1.38–3.81], p = 0.001 and HR 2.61 [95% CI 1.76–3.89], p < 0.001, respectively) and ≥ 2 cm (HR 3.10 [95% CI, 1.62–5.94], p < 0.001 and HR 3.03 [95% CI 1.92–4.79], p < 0.001, respectively) displayed greater local recurrence compared to tumors < 0.5 cm. In addition, among patients treated with stereotactic radiation, significantly higher risk of radiographic and symptomatic necrosis was observed in tumors ≥ 0.5 cm versus < 0.5 cm at radiotherapy, with hazard ratios ranging from 3.27 to 18.90.

Conclusion

Larger metastasis size is associated with markedly poorer local control and increased necrosis following brain-directed radiation, suggesting a role for earlier utilization of radiation therapy in patients with small, asymptomatic metastases and a favorable prognosis.